SCHEMBL4958312

SCHEMBL4958312

CCCCc1nc2ccccc2c(=O)n1C1CCC(N)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.56
▸ ATM Q13315 2/20 0.56
▸ LMNA P02545 6/20 0.55
▸ TSHR P16473 4/20 0.55
▸ PDE4A P27815 1/20 0.54
▸ PDE4B Q07343 1/20 0.54
▸ PDE4C Q08493 1/20 0.54
▸ PDE4D Q08499 1/20 0.54
▸ ALDH1A1 P00352 4/20 0.52
▸ MAPK1 P28482 2/20 0.52
▸ GAA P10253 2/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ NPSR1 Q6W5P4 4/20 0.47
▸ MAPT P10636 2/20 0.47
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4961819 0.99 SMN1; SMN2 (0.55) SMN1; SMN2ATMLMNATSHRPDE4A
SCHEMBL4960927 0.86 PDE4A (0.54) SMN1; SMN2ATMLMNATSHRPDE4A
Hydrochloric Acid SCHEMBL4960041 0.85 PDE4A (0.53) SMN1; SMN2ATMLMNATSHRPDE4A
SCHEMBL4958854 0.84 LMNA (0.50) SMN1; SMN2ATMLMNATSHRPDE4A
SCHEMBL4957260 0.83 LMNA (0.52) SMN1; SMN2ATMLMNATSHRPDE4A
SCHEMBL4959745 0.78 MAPT (0.55) SMN1; SMN2ATMLMNATSHRPDE4A
SCHEMBL14115053 0.78 HDAC6 (0.47) SMN1; SMN2ATMLMNATSHRPDE4A
SCHEMBL4958732 0.78 MAPT (0.50) SMN1; SMN2ATMLMNATSHRPDE4A
SCHEMBL18076647 0.77 TSHR (0.51) SMN1; SMN2ATMLMNATSHRALDH1A1
SCHEMBL5928664 0.76 SMN1; SMN2 (0.92) SMN1; SMN2ATMLMNATSHRPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 — — WO claimed
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 — — WO disclosed
Send feedback